NYSE: ANVS
Annovis Bio Inc Stock Ownership - Who owns Annovis Bio?

Insider buying vs selling

Have Annovis Bio Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michael B. HoffmanDirector2025-06-1325,000$2.80
$70.00kBuy
Michael B. HoffmanDirector2025-06-131$2.83
$2.83Buy
Reid McCarthyDirector2025-06-102,000$2.95
$5.90kBuy
Marialuisa MacCecchiniPresident CEO2025-06-0446,000$3.37
$155.02kBuy
Michael B. HoffmanDirector2025-05-295,000$2.43
$12.15kBuy

1 of 1

ANVS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ANVS insiders and whales buy or sell their stock.

ANVS Shareholders

What type of owners hold Annovis Bio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Michael B. Hoffman8.57%1,669,641$4.69MInsider
Marialuisa MacCecchini5.72%1,114,459$3.13MInsider
Vanguard Group Inc3.33%647,920$1.82MInstitution
Two Sigma Investments LP0.85%166,219$467.08kInstitution
Ubs Group Ag0.83%160,876$452.06kInstitution
Geode Capital Management LLC0.78%152,613$428.84kInstitution
Susquehanna International Group LLP0.66%127,705$358.85kInstitution
Blackrock Inc0.52%100,629$282.77kInstitution
Merit Financial Group LLC0.50%97,816$274.86kInstitution
Jr Robert M. Whelan0.49%95,700$268.92kInsider

1 of 3

ANVS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ANVS10.71%15.45%Net BuyingNet Buying
PRLD48.16%51.84%Net BuyingNet Buying
ONCY1.58%0.00%
CNTX79.60%1.46%Net BuyingNet Buying
PMVP57.32%42.68%Net Buying

Annovis Bio Stock Ownership FAQ

Who owns Annovis Bio?

Annovis Bio (NYSE: ANVS) is owned by 10.71% institutional shareholders, 15.45% Annovis Bio insiders, and 73.84% retail investors. Michael B. Hoffman is the largest individual Annovis Bio shareholder, owning 1.67M shares representing 8.57% of the company. Michael B. Hoffman's Annovis Bio shares are currently valued at $4.73M.

If you're new to stock investing, here's how to buy Annovis Bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.